ReachMD

Henry D. Jampel, MD, MHS, Odd Fellows Professor of Ophthalmology, was raised in the home of an academic ophthalmologist, and hence was exposed to ophthalmology at an early age. After graduating from Harvard summa cum laude in Biology, he attended the Yale University School of Medicine where he met his wife Risa, a dermatologist who has been part of the Johns Hopkins community for almost 30 years. They have three children, Catherine, a Harvard graduate, Joseph, who is a senior at Harvard, and Sarah, who is a freshman at Yale. The decision to enter the field of ophthalmology came late during medical school, and when he sought his father, Dr. Robert Jampel's, advice about where he should train, he was told "Wilmer, if you can get in."

After completing his residency at Wilmer, Dr. Jampel was encouraged to stay at Wilmer for an extended glaucoma fellowship with Harry Quigley, M.D., A.E. Maumenee Professor of Ophthalmology, and Irvin Pollack, M.D., Professor Emeritus. Dr. Quigley doubled the faculty of the Glaucoma Service in 1988 by adding Dr. Jampel as his colleague. Dr. Jampel went back to school as an Associate Professor and obtained a Master's degree in Health Finance and Management.

Dr. Jampel's research career has encompassed both laboratory and clinical research. He was a principal investigator on the Collaborative Initial Glaucoma Treatment Study, a multi-center study comparing medical and surgical treatment for glaucoma in newly diagnosed patients. He was also an investigator, along with fellow faculty member Don Zack, M.D., Ph.D., Guerrieri Family Professor of Ophthalmology, in the Ocular Hypertension Treatment Study. He is actively collaborating with Dr. David Friedman, M.D., MPH, Alfred Sommer Professor of Ophthalmology, and Dr. Michael Boland on a government funded project assessing the value of screening and treating glaucoma. Dr. Jampel has collaborated with the team of Ran Zeimer, Ph.D., Morton F. Goldberg Professor of Ophthalmology, and Susan Vitale, Ph.D., M.H.S., on imaging devices for the detection of glaucoma and its progression. Throughout all of his endeavors, Dr. Jampel has been assisted by his study coordinator and administrator, Rhonda Miller, C.O.A. He observes "The opportunity to collaborate with brilliant vision scientists at Wilmer is what really makes the research enjoyable."

Dr. Jampel's interests in ophthalmology are broad and his service to the field considerable. Since 2003, he has been the Associate Editor-in-Chief of Ophthalmology, one of the most prestigious clinical journals in the field. He chairs the American Academy of Ophthalmology's Ophthalmic Technology Assessment Panel, which evaluates the role of devices in the diagnosis and management of glaucoma. He is current chairman of the Research Committee of the American Glaucoma Society and has recently authored a position statement on the use of marijuana to treat glaucoma. Closer to home at Wilmer, for the past 5 years, Dr. Jampel has served as medical director of Wilmer's Green Spring Station satellite office, where he oversees the outpatient clinic, the Laser Vision Center, and the Ambulatory Surgery Center.